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Kielmeyera  coriacea  Mart.  (Calophyllaceae)  is  known  popularly  as  “Pau  Santo”.  The hydroethanolic  extract
(HE) of  Kielmeyera  coriacea  stems  and  its semi-pure  dichloromethane  (DCM)  constituent  produced  an
antidepressant-like  effect  in  rats.  The  purpose  of  this  study  was  to  investigate  the  effects  of repeated
administration  (21  days)  by gavage  of  the  DCM  fraction  (5,  10 or 15  mg/kg)  in  rats  submitted  to  the
elevated  T-maze  (ETM),  a  model  of  generalized  anxiety  and  panic  disorders.  The  tricyclic  antidepres-
sant  imipramine  (15 mg/kg)  was  used  as  a  positive  control.  Rat  locomotion  was  assessed  using  the
open  ﬁeld  test  (OFT)  following  each  drug  treatment.  The  2-hydroxy-1-methoxyxanthone  (1),  aucuparin
(2), swertinin  (3),  1,3,7-trihydroxy-2-(3-methylbut-2-enyl)-xanthone  (4)  and  1,3,5-trihydroxy-2-(3-
methylbut-2-enyl)-xanthone  (5)  were  identiﬁed  in  DCM  fraction,  and  suggest  that  the  xanthone  (4)  is
related  with  the  antidepressant-like  proﬁle  of  this  plant.  Pharmacological  evaluation  showed  that  DCM
fraction  (10  and  15  mg/kg)  decreased  the  inhibitory  avoidance  latency  from  the  closed  arm  and  increased
the one-way  escape  latency  from  the  open  arm  in  the  ETM,  which  is  indicative  of  anxiolytic  and  pani-
colytic  effects,  respectively,  as  occurs  with  the  positive  control,  imipramine  (15  mg/kg),  when  compared
to their  control  group  (vehicle).  Locomotor  activity  was  not  signiﬁcantly  altered  by the  different  treat-
ments.  This  study  suggests  that  the  DCM  fraction  from  stems  of  Kielmeyera  coriacea  can  be an important
therapeutic  alternative  in  the  treatment  of  anxiety  disorders,  such  as  generalized  anxiety  and  panic
disorders.
© 2011 Elsevier GmbH. Open access under the Elsevier OA license. ntroduction
Anxiety disorders, such as generalized anxiety disorder, panic
isorder, obsessive-compulsive disorder and phobias, are the most
ommon psychiatric conditions (Kessler et al. 2005). The high
revalence of psychiatric diseases is associated with occupational
imitations, emotional problems (Schonfeld et al. 1997), lower
ikelihood of satisfaction in family life, in one’s sense of overall
ell-being (Stein and Heimberg 2004) and impaired quality of life
Henning et al. 2007), resulting in high costs to the public health
ystem (Henderson et al. 2005).
Due to the high comorbidity between anxiety and depressive
isorders, antidepressants compounds are considered ﬁrst-line
edications in the treatment of these pathologies (Hoffman and
athew 2008).
Although the available pharmacological treatments for these
isorders are effective, they have many limitations, including
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Open access under the Elsevier OA license. initial worsening of anxiety symptoms, sleep disturbances, sex-
ual side effects, gastrointestinal problems, weight gain, drug–drug
interactions, withdrawal and dependence issues (Baldessarini
2006).
For this reason, and because of their prevalence and the high
degree of suffering they cause, anxiety disorders are among the
most common reasons for searching for complementary therapies
(Eisenberg et al. 1998) and self-medication with medicinal herbs
(Astin 1998).
It is estimated that Brazil has the greatest plant biodiversity
in the world (Guerra and Nodari 2001), and Kielmeyera coriacea
Mart. (Calophyllaceae), known as “Pau Santo”, is just one of many
potentially useful plants available.
The hydroethanolic extract (HE) of Kielmeyera coriacea stems
(60 mg/kg) and its semi-pure dichloromethane (DCM)  constituent
(5 mg/kg), but not the extract of Kielmeyera coriacea leaves
(30–120 mg/kg) (Audi et al. 2002), reduce immobility time in the
forced swimming test (FST), without altering locomotor activity in
the open-ﬁeld test (OFT), as occurs with tricyclic antidepressant
imipramine (20 mg/kg), when chronically administered (Martins
et al. 2004, 2006), suggesting an antidepressant-like proﬁle. The HE
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Fig. 1. High performance liquid chromatography chromatogram of DCM frac-
tion  from stem of Kielmeyera coriacea. Conditions: Phenomenex ODS column;
step  gradient of acetonitrile–water (containing 0.05% triﬂuoroacetic acid):
30  → 100% CH3CN over 40 min; ﬂow rate 0.6 ml/min; temperature: 40 ◦C; detec-C. Biesdorf et al. / Phyto
f Kielmeyera coriacea stems inhibits in a concentration-dependent
anner the synaptosomal uptake of [3H] serotonin (5-HT), [3H]
oradrenaline (NA) and [3H] dopamine (DA) (Goulart et al. 2007),
uggesting that these neurotransmitters are involved in the mech-
nism of action.
The aim of this work was to assess the anxiolytic and panicolytic
ffects of the DCM fraction on rats subjected to the elevated T-maze
ETM) test.
aterials and methods
lant material
Kielmeyera coriacea was collected near Mogi Guac¸ u (São Paulo,
razil) in December 2007. The analysis and identiﬁcation of
ielmeyera coriacea were carried out by Dr. Maria Claudia Young
f the Instituto Botânico de São Paulo. A voucher specimen
#SP 298463) was deposited with the Herbarium of the insti-
ute.
xtraction and fractionation
Dried and crushed stems (2 kg) of Kielmeyera coriacea were
xhaustively extracted with ethanol/water (9:1) at room temper-
ture, yielding 342.1 g of extract after evaporation of the solvents
nd lyophilization. The lyophilized extract (329.8 g) obtained from
ielmeyera coriacea stems was submitted to vacuum-column chro-
atography on silica gel (70–230 mesh) using step gradient elution
ith hexane, CH2Cl2, AcOEt, acetone and MeOH–H2O (9:1) to yield
ve fractions (F1: 3.8 g), (F2: 33.6 g), (F3: 48.6 g), (F4: 39.1 g) and
F5: 198.7 g) after the organic solvent was removed under vacuum
t 40 ± 1 ◦C. The different compounds in DCM fraction from stems
f Kielmeyera coriacea were identiﬁed by comparison with standard
amples and by analysis of HPLC–UV.
ehavioral tests
nimals
Male Wistar rats weighing 230–250 g (55 days) were used
n this study and housed in groups of four per cage, with food
nd water freely available. The animals were maintained on a
2-h light:dark cycle (lights on at 07:00 h) under controlled tem-
erature (22 ± 1 ◦C). All experiments were carried out between
8:00 and 12:00 h. The experimental procedures adopted were
pproved by the UEM Ethics Committee (049/2010-CEEA), and
ollowed the norms recommended as international guiding prin-
iples for Biomedical Research Involving Animals (CIMS), Geneva,
985.
rugs
DCM fraction was solubilized in saline (0.9% NaCl) containing 3%
ween 80. Imipramine chlorhydrate was used as positive control
Cristália). The control group was treated with the vehicle (0.9%
aCl plus 3% Tween 80).
levated T-maze (ETM) and open ﬁeld test (OFT)
The tests employed were similar to that described by Roncon
t al. (2010).
reatment
To determine the dose-response curve of DCM fraction, the ani-
als were treated for 21 days with DCM (5, 10 and 15 mg/kg,
 = 10–15) or vehicle (n = 12) by gavage (i.g.) route or imipramine
15 mg/kg, n = 10) by intraperitoneal (i.p.) route. On the 20th day,
he pre-tests were carried out, in which the animals were con-
ned in one of the open arms of the ETM for 30 min, and aftertion UV 254 nm.  2-Hydroxy-1-methoxyxanthone (1); aucuparin (2); swertinin
(3);  1,3,7-trihydroxy-2-(3-methylbut-2-enyl)-xanthone (4); 1,3,5-trihydroxy-2-(3-
methylbut-2-enyl)-xanthone (5).
the pre-test received their treatment (drugs or vehicle). On  the
21st day of treatment, the animals were treated (drugs or vehicle)
and submitted to the behavioral tests 60 min after the treat-
ment.
Statistical analysis
Repeated measure analyses of variance (RMANOVA) were used
to analyze both avoidance and escape data. The treatments were
considered as the independent factors, and the tests (baseline,
avoidance 1–2 and escape 1–3) as the repeated measures. When
appropriate, one-way ANOVA followed by Duncan’s post hoc mul-
tiple comparison test were used. Locomotion data were analyzed by
one-way ANOVA followed by Duncan’s post hoc multiple compar-
ison test. Differences between groups were considered signiﬁcant
if p ≤ 0.05.
Results
The 2-hydroxy-1-methoxyxanthone (1), aucuparin (2), swer-
tinin (3), 1,3,7-trihydroxy-2-(3-methylbut-2-enyl)-xanthone (4)
and 1,3,5-trihydroxy-2-(3-methylbut-2-enyl)-xanthone (5) were
identiﬁed, with retention times of 17.0 min, 21.1 min, 22.3 min,
24.6 min  and 27.2 min, respectively (Fig. 1).
Fig. 2 shows the effects of repeated administration of vehi-
cle (control group), imipramine (15 mg/kg), or DCM (5, 10, or
15 mg/kg) in the ETM and OFT, respectively. The RMANOVA for the
inhibitory avoidance test showed a signiﬁcant main effect on the
trials [F(2,108) = 15.53; p < 0.001], on the treatment [F(4,54) = 2.94;
p = 0.02] and on the treatment × trial interaction [F(8,108) = 2.16;
p = 0.03]. Post hoc comparisons showed that imipramine (*p  < 0.05),
DCM 10 mg/kg and 15 mg/kg (**p < 0.01) decreased avoidance 2
latency compared to the control group, indicating an anxiolytic
effect.
For the escape test, the RMANOVA showed a signiﬁcant
main effect on treatment [F(4,54) = 13.13; p < 0.001] and on the
trials [F(2,108) = 3.25; p = 0.04], but not a signiﬁcant effect on
treatment × trial interaction [F(8,108) = 0.68; p = 0.70]. Post hoc
comparisons showed that imipramine increased escape 1, 2 and
3 latencies (***p < 0.001), DCM 10 and 15 mg/kg signiﬁcantly
increased escape 2 (*p = 0.05 and **p < 0.01, respectively) and DCM
15 mg/kg signiﬁcantly increased escape 3 (**p < 0.01) latencies
compared to the control group, indicating a panicolytic effect.
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aig. 2. Effects (mean ± SEM) of 21 days of administration of DCM or imipramine
n  inhibitory avoidance and escape latencies in the ETM test (n = 10–15). *p ≤ 0.05;
*p ≤ 0.01; ***p ≤ 0.001 compared to the control group.
ne-way ANOVA did not show signiﬁcant differences in dis-
ance traveled in meters in the OFT (p > 0.05, n = 10–15) under
he different treatments imipramine (15 mg/kg = 16.2 ± 1.2); DCM
5 mg/kg = 21.8 ± 1.2; 10 mg/kg = 16.5 ± 1.1; 15 mg/kg = 16.1 ± 1.0)
ompared to the control group (18.9 ± 1.1).
iscussion
This study evaluated the effects of DCM fraction on rats in the
TM test, an animal model developed to assess defensive behaviors
elated to speciﬁc subtypes of anxiety disorder, generalized anxiety
isorder and panic disorder.
The data obtained showed that repeated treatment with DCM
ecreased inhibitory avoidance latency and increased escape
atency without affecting the locomotion in the OFT, as occurs with
he reference drug, imipramine. DCM was therefore found to have
n anxiolytic and panicolytic effect on rats in the ETM test.
The phytochemical investigations on Kielmeyera coriacea led
o the isolation and identiﬁcation of ten xanthones, one biphenyl
nd two triterpenes (Cortez et al. 1998). Studies showed that
,3,7-trihydroxy-2-(3-methylbut-2-enyl)-xanthone isolated from
ielmeyera coriacea and presented in DCM fraction is related with
he antidepressant-like proﬁle of this plant suggested by the anti-
mmobility effect in the FST (Martins et al. 2008; Sela et al. 2010).
Some studies show that xanthone derivatives (Ohishi et al. 2000)
nd xanthones present in the plant Gentiana kochiana, which show
ntidepressant therapeutic potential (Tomic et al. 2005), are able
o inhibit monoamine oxidases (MAO), a mechanism in a class of
ntidepressants, establishing a relation between xanthones andine 19 (2012) 374– 377
antidepressant activity. Others studies also showed that xanthones
are able to inhibit the type A and type B MAO  (Suzuki et al. 1981)
and according to pharmacological investigations xanthones must
be involved in the antidepressant effect of a standardized Hyper-
icum perforatum extract (Butterweck et al. 1997).
The DCM fraction of Kielmeyera coriacea was evaluated in a tox-
icological study and showed an LD50 of 1.503 mg/kg by oral route
and 538.8 mg/kg by intraperitoneal route in mice, indicating the
safety of acute and repeated oral administration of the DCM fraction
of Kielmeyera coriacea stems, which can therefore be continuously
used with safety (Obici et al. 2008).
In conclusion, the results of the present study demonstrate that
DCM is active orally, and produces an anxiolytic and panicolytic
effect on rats in the ETM test. The results suggest that DCM could
be a useful drug in the treatment of mood disorders such as gener-
alized anxiety and panic disorder.
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